This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The contract is a delivery order for the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, valued at $2,675.08. It has a firm fixed price pricing type and a completion date of March 1, 2024.
Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This award does not have a set-aside designation.
Generated 5/30/24, 9:58 AM